🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Happy Postdoc Appreciation Week to my favorite postdocs! Thank you for all the laughs, sunny lunches/boba walks, and ongoing support ☀️ Ronda F. Lo Efraín García Sánchez Mikaela Spruill @cintiaphinojosa SPARQ

Stop staring at a blank page. • Abstract: Rationale, methods, results, implication • Intro: Context, problem, hypothesis • Methods: Design, subjects, measures • Results: Data, figures, observations • Discussion: Interpret results, compare studies Write with confidence.

Had a great start to the quarter at Stanford University! Enjoyed hearing about Rachael Yielder Health Psychology Auckland PhD research in our lab meeting (yay for another Kiwi accent!!) & loved catching up at the Psych Dept welcome. Here’s to an inspiring year ahead! 🌲

We are hosting our annual Paths to PhD - a student-led virtual info session & workshop for anyone considering applying to research positions and PhD programs in psychology - on Oct 26, 2024 Application is open now and due on Sep 29! bit.ly/paths2phd24

🎉 It was great to see our PhD students Rachael Yielder and Jane C, and recent alum Chiara Gasteiger, PhD sharing their research at the recent European Health Psychology Society convention in Portugal, and catching up with other early career researchers from across the globe! 👏🌅 Faculty of Medical and Health Sciences UoA Stanford Psychology

Bryant Lin, MD, has taken his diagnosis of stage IV ‘never-smoker’ lung cancer, which disproportionately affects those of Asian descent, and turned it into a medical school course. He hopes the world takes notes along with his students. scopeblog.stanford.edu/2024/10/16/nev…

Excited to share our latest study in Health Psychology led by Rachael Yielder Health Psychology Auckland 🩺 We demonstrate that word clouds offer a low-burden approach to capturing patient experiences of living w/ inflammatory arthritis ☁️💊 @NicolaDalbeth @KeithPetrie doi.org/10.1037/hea000…

Stanford Study Evaluates the Social Impact of Chronic Pain Managing chronic pain isn’t just about reducing pain or improving physical function. It also impacts social life and mental health. Pain treatment should focus on social well-being as much as on pain relief. Why it

Had the honor of guest lecturing for Stanford’s Intro to Psych course last week! Grateful for the opportunity to share & learn alongside such brilliant students 🗣️ Stanford Psychology

So deeply inspiring hearing Natasha Steele, MD, MPH Diana Cejas, MD, MPH #BryantLin Stanford Medicine share their journeys with cancer & how their experiences now shape their care & communication. Thank you for your strength, raw honesty & insights - I’ll be reflecting on this for a long time 🙏

Holy crap! Literally💩 Totally amazing project worth checking out:

Do open label placebos cause side effects? The results might surprise you! Our study shows that OLPs increased symptoms & negative mood immediately after & 24 h later 💊 A/Prof Kate Faasse @keithpetrie Health Psychology Auckland Journal of Psychosomatic Research doi.org/10.1016/j.jpsy…

I‘ve finally given in and joined the other club! 🦋 You can find me under my full name 👋🏻

Editorial: Infrequent Zoledronate — Small Individual Gain, Larger Population Gain nej.md/4hgR1Wh

Thrilled to see our latest study published in NEJM ✨🦴 Faculty of Medical and Health Sciences Stanford Psychology SPARQ

Original Article: Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age nej.md/4g6wlz3 Editorial: Infrequent Zoledronate — Small Individual Gain, Larger Population Gain nej.md/4hgR1Wh #Orthopedics

In a new trial, researchers assessed whether very infrequent zoledronate infusions would prevent vertebral fractures in early postmenopausal women without osteoporosis. Full trial results and Plain Language Summary: nej.md/4g6wlz3

Zoledronate prevents fractures when given every 12 to 18 months, but its effects on bone health persist well beyond 5 years. Research findings on very infrequent zoledronate dosing in early postmenopausal women are summarized in a Quick Take video. nej.md/3C2CgHN